Apollomics Stock (NASDAQ: APLM) stock price, news, charts, stock research, profile.
Open | $0.402 |
Close | $0.372 |
Volume / Avg. | 200.057K / 176.555K |
Day Range | 0.361 - 0.418 |
52 Wk Range | 0.361 - 6.450 |
Market Cap | $33.292M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 24 |
Short Interest | 0.28% |
Days to Cover | 1.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Apollomics (NASDAQ: APLM) through any online brokerage.
Other companies in Apollomics’s space includes: NKGen Biotech (NASDAQ:NKGN), Fortress Biotech (NASDAQ:FBIO), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP) and OncoCyte (NASDAQ:OCX).
The latest price target for Apollomics (NASDAQ: APLM) was reported by HC Wainwright & Co. on Wednesday, May 8, 2024. The analyst firm set a price target for 2.00 expecting APLM to rise to within 12 months (a possible 437.63% upside). 9 analyst firms have reported ratings in the last year.
The stock price for Apollomics (NASDAQ: APLM) is $0.372 last updated May 10, 2024 at 7:14 PM EDT.
There are no upcoming dividends for Apollomics.
Apollomics’s H1 earnings are confirmed for Wednesday, August 7, 2024.
There is no upcoming split for Apollomics.
Apollomics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.